Development of newly synthesised quinazolinone-based CDK2 inhibitors with potent efficacy against melanoma
Inhibiting Cyclin-dependent kinase 2 (CDK2) has been established as a therapeutic strategy for the treatment of many cancers. Accordingly, this study aimed at developing a new set of quinazolinone-based derivatives as CDK2 inhibitors. The new compounds were evaluated for their anticancer activity ag...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | 図書 |
| 出版事項: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
| 主題: | |
| オンライン･アクセス: | Connect to this object online. |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
このレコードへの初めてのコメントを付けませんか!